Good Clinical Podcast

Implications of ICH E6(R3) on Risk-Based Clinical Trial Practice

Good Clinical Podcast: Season 2, Episode 3

How ICH E6(R3) will impact Good Clinical Practice and clinical trial innovation

On this episode of ACRO’s Good Clinical Podcast, Nicole Stansbury (SVP, Global Clinical Operations, Premier Research) and Madeleine Whitehead (RBQM Product & People Lead, Roche) join the podcast to discuss ACRO’s collaboration with TransCelerate BioPharma, Inc., the impact that ICH E6(R3) will have on Good Clinical Practice, and implications for innovation.

They dive deeper into the benefits of a risk-based approach, regulators’ thoughts on making clinical research more agile, and the potential to help industry bring medicines to patients more efficiently.

This episode is available to stream on Spotify, Apple Podcasts, and YouTube.

Subscribe for Updates

The Association of Clinical Research Organizations (ACRO) represents the leading clinical research and technology companies around the world. In our newsletter, we bring you updates on our work and the impact that we are having in advancing the global clinical research industry.

Contact Information(Required)
Please select if you're a member of the media.
Scroll to Top